ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 556 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Adding Blinatumomab to Consolidation Chemotherapy Improves OS in Adult Patients in... August 12, 2024 FDA Approves Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma October 27, 2025 Immune Responses Similar for Adjuvanted and Standard Dose Influenza Vaccines for... February 4, 2025 Low Dose Dexamethasone Effective as Premedication for Taxanes to Prevent Hypersensitivity... August 10, 2021 Load more HOT NEWS EMA Recommends Extension of Therapeutic Indications for Polatuzumab Vedotin Weekend in New England Saving Time for Patients and Improving Well-Being Through Mindfulness and Fitness:... Delivering Palliative Care by Telehealth Meets the Needs of People with...
